4 December 2023
HeiQ Plc
("HeiQ" or "the Company")
Director / PDMR Dealing
HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, has been notified that on 1 December 2023, Karen Brade, Non-Executive Director, purchased 32,287 ordinary shares in the Company ("Ordinary Shares") at a price of 15.372 pence per share.
Following the purchase, Mrs. Brade holds an interest in 40,263 Ordinary Shares. The total interest held by Mrs. Brade represents approximately 0.03 per cent of the Company's issued ordinary share capital.
This announcement, including the notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Karen Brade | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Non-Executive Director | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| HeiQ plc | ||||
| b)
| LEI
| 213800IGT65IMJDO4S03 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 30 pence each
GB00BN2CJ299
| ||||
| b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A
| ||||
| e)
| Date of the transaction
| 1 December 2023 | ||||
| f)
| Place of the transaction
| London Stock Exchange, Main Market | ||||
For further information, please contact:
| HeiQ Plc Carlo Centonze (CEO) | +41 56 250 68 50 |
| Cenkos Securities plc (Joint Broker) Stephen Keys / Callum Davidson | +44 (0) 207 397 8900 |
| SEC Newgate (Media Enquiries) Elisabeth Cowell / Tom Carnegie / Molly Gretton | +44 (0) 20 3757 6882 |
About HeiQ
HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.
Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.
We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.
We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.